US Patent Issued to GLADIATOR BIOSCIENCES on Jan. 20 for "Gla domains as targeting agents" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,836, issued on Jan. 20, was assigned to GLADIATOR BIOSCIENCES INC. (Mill Valley, Calif.).

"Gla domains as targeting agents" was invented by Maxine Bauzon (Hercules, Calif.) and Terry Hermiston (Mill Valley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to the recombinant Gla domain proteins and their use targeting phosphatidylserine (PtdS) moieties on the surface of cells, particularly those expressing elevated levels of PtdS, such as cells undergoing apoptosis. These proteins can be linked to both diagnostic and therapeutic payloads, thereby permitting identification and treatment of cells expression elevated PtdS." ...